Your browser doesn't support javascript.
loading
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.
Forsberg, Peter A; Rossi, Adriana C; Boyer, Angelique; Pearse, Roger N; Pekle, Karen A; Jayabalan, David; Lakritz, Stephanie; Flicker, Kari; Ribadeneyra, Drew; Liotta, Brielle; Ely, Scott; Boussi, Leora; Allan, John N; Coleman, Morton; Niesvizky, Ruben; Mark, Tomer M.
Afiliação
  • Forsberg PA; Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Rossi AC; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Boyer A; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Pearse RN; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Pekle KA; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Jayabalan D; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Lakritz S; Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Flicker K; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Ribadeneyra D; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Liotta B; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Ely S; Bristol-Myers Squibb, New York, New York, USA.
  • Boussi L; New York Medical College, Valhalla, New York, USA.
  • Allan JN; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Coleman M; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Niesvizky R; Department of Medicine, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.
  • Mark TM; Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Am J Hematol ; 96(12): 1554-1562, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34424561
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Claritromicina / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Claritromicina / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos